The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy

NCT00732654 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Milk Allergy

Interventions

DRUG: Milk Protein Extract Immunotherapy goal of 4mg/day
DRUG: Milk Protein Extract Immunotherapy goal of 7mg/day
DRUG: Milk Powder Immunotherapy goal dose 2000 mg/day
DRUG: Milk Powder Immunotherapy goal dose 1000mg/day

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]